Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Update on differenciated thyroid carcinoma].

Lucie Karayan1, Samy Hadjadj, Christian J Larsen

  • 1Service d'endocrinologie-diabétologie, CHU, BP 577, 86021 Poitiers Cedex.

Bulletin Du Cancer
|February 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to the Letter to the Editor Entitled "A Missing Genomic Dimension: The Small but Central Mitochondrial Genome in Diabetic Kidney Disease Genetics".

Kidney international reports·2026
Same author

CGM-based metrics and mortality in older adults living with type 2 diabetes on insulin therapy: a secondary analysis of the HYPOAGE study.

Diabetes & metabolism·2026
Same author

Impact of high intensity physical activity compared to routine counseling on renal function decline in patients with type 2 diabetes at high risk for kidney disease - the ACTIDIANE randomized controlled trial.

Diabetes & metabolism·2026
Same author

Risk stratification of MASLD-related advanced fibrosis using a novel point-of-care device: the Hepatoscope.

Diabetes & metabolism·2026
Same author

Accuracy of Dexcom G6® and FreeStyle Libre® Sensors in Standardized Hypoxia Conditions: A Randomized Controlled Trial-FOX Study.

Diabetes technology & therapeutics·2026
Same author

Risk score for lower-limb amputation and its ability to predict major kidney and cardiovascular events in people with type 1 diabetes.

Cardiovascular diabetology·2026
Same journal

[Off-label use of venetoclax in myeloma].

Bulletin du cancer·2026
Same journal

[Cemiplimab - Adjuvant treatment for the cutaneous squamous cell carcinomas with high risk of relapse, operated and treated by radiotherapy].

Bulletin du cancer·2026
Same journal

Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).

Bulletin du cancer·2026
Same journal

[Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)].

Bulletin du cancer·2026
Same journal

[Reirradiation: A new therapeutic paradigm in oncology].

Bulletin du cancer·2026
Same journal

[Robotics in oncological surgery].

Bulletin du cancer·2026
See all related articles

Differentiated thyroid carcinomas, common endocrine tumors, have a good prognosis. Molecular biology advances improve diagnosis and treatment, including recombinant human TSH, and aid in managing familial thyroid cancer.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Context:

  • Differentiated thyroid carcinomas are the most common endocrine tumors.
  • These tumors are hormone-dependent and generally have a favorable prognosis.
  • Understanding the molecular basis of thyroid tumorigenesis is crucial.

Purpose:

  • To review the role of molecular biology in understanding thyroid cancer.
  • To highlight advancements in diagnostic and therapeutic management.
  • To emphasize the importance of recognizing familial thyroid cancer.

Summary:

  • Molecular biology has elucidated pathophysiological mechanisms in papillary and follicular thyroid carcinomas.
  • Recombinant human TSH represents a significant advancement in patient management.

Related Experiment Videos

  • Identifying familial thyroid cancer is key for optimizing clinical care for patients and their relatives.

    • Impact:

    • Improved understanding of thyroid cancer development.
    • Enhanced diagnostic and therapeutic strategies for thyroid cancer patients.
    • Better clinical management protocols for familial thyroid cancer cases.